Literature DB >> 6428442

Renal actions of a uricosuric diuretic, racemic indacrinone, in man: comparison with ethacrynic acid and hydrochlorothiazide.

B A Brooks, A F Lant, W R McNabb, F H Noormohamed.   

Abstract

The effects of indacrinone (IND) have been investigated in a two part study. First, a total of 36 clearance studies have been performed in 14 healthy volunteers, under conditions of either maximal hydration or hydropenia, to compare the renal sites of action of single oral doses of IND, 20 mg, ethacrynic acid (EA), 100 mg, and hydrochorothiazide (HCTZ), 100 mg. Under conditions of maximal water hydration, IND increased fractional Na+ excretion from a mean of 1.19 +/- 0.05 to 4.93 +/- 0.67% of GFR. This was similar to the response seen with HCTZ, which increased fractional Na+ clearance up to 3.16 +/- 0.17% of GFR; EA increased fractional Na+ excretion up to 14.5 +/- 2.5% of GFR. The mean reduction in fractional free-water clearance (CH2O/GFR X 100%) invoked by IND, (delta = -34.8% of control) was similar to that produced by EA, (delta = -27.2% of control), and by HCTZ, (delta = -26.6% of control). During hydropenia with superimposed mannitol diuresis, both IND and EA caused a fall in fractional free-water reabsorption (TcH2O/GFR X 100%), delta IND = -20.3% of control, delta EA = -70.1% of control. HCTZ produced a significant increase in fractional free-water reabsorption, delta HCTZ = -20.7% of control. In all studies, single doses of IND were both uricosuric and hypouricaemic. Fractional urate excretion increased from a mean 6.7 +/- 0.1 to 15.2 +/- 2.1% of GFR whilst plasma urate concentration fell from a mean of 0.36 +/- 0.03 to 0.34 +/- 0.03 mM (P less than 0.05) within 2-3 h post drug. HCTZ and EA, in single doses, had little effect on urate excretion. In the second part of the study, a total of 16 healthy volunteers received either IND, 10 mg, or HCTZ 50 mg, orally for 8 days, whilst on a diet of controlled electrolyte content. Both drugs were well tolerated by both sets of subjects with no adverse clinical or pathological findings. Both IND and HCTZ caused a significant reduction in weight and standing systolic blood-pressure during the first 48 h of therapy. At the doses administered, IND and HCTZ displayed similar diuretic responses with respect to water, Na+, Cl-, Ca2+ and PO4(3-) excretion. IND produced less kaliuresis than HCTZ during the first treatment day but cumulative K+ loss was similar for both drugs over the eight days of therapy. Fractional urate excretion after IND remained elevated throughout the 8 days of therapy and the subjects remained isouricaemic for 7 days.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428442      PMCID: PMC1463457          DOI: 10.1111/j.1365-2125.1984.tb02382.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  40 in total

1.  Some aspects of the renal action and clinical pharmacology of oral bumetanide in man.

Authors:  E Bourke
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

2.  The effects of indanyloxyacetic acid (mk 196) on electrolyte excretion in the rat kidney.

Authors:  R McKenzie; T Knight; E J Weinman
Journal:  Proc Soc Exp Biol Med       Date:  1976-11

3.  Phosphate transport along the nephron.

Authors:  F G Knox; H Osswald; G R Marchand; W S Spielman; J A Haas; T Berndt; S P Youngberg
Journal:  Am J Physiol       Date:  1977-10

Review 4.  Urate excretion.

Authors:  G M Fanelli
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

5.  Renal action, therapeutic use, and pharmacokinetics of the diuretic bumetanide.

Authors:  D L Davies; A F Lant; N R Millard; A J Smith; J W Ward; G M Wilson
Journal:  Clin Pharmacol Ther       Date:  1974-02       Impact factor: 6.875

6.  Effects of metolazone in man: comparison with chlorothiazide.

Authors:  S T Steinmuller; J B Puschett
Journal:  Kidney Int       Date:  1972-03       Impact factor: 10.612

7.  Mechanisms of the uricosuric effect of the diuretic tienilic acid (Ticrynafen) in man.

Authors:  K Lau; R M Stote; M Goldberg; Z S Agus
Journal:  Clin Sci Mol Med       Date:  1977-10

8.  Renal excretion of a slauretic-uricosuric agent (MK-196) and interaction with a urate-retaining drug, pyrazinoate, in the chimpanzee.

Authors:  G M Fanelli; D L Bohn; A G Zacchei
Journal:  J Pharmacol Exp Ther       Date:  1977-02       Impact factor: 4.030

9.  Diuretic-induced uricosuria: interaction with pyrazinoate transport in man.

Authors:  D R Prasad; I M Weiner; T H Steele
Journal:  J Pharmacol Exp Ther       Date:  1977-01       Impact factor: 4.030

10.  Dissociation of urate from sodium transport in the rat proximal tubule.=.

Authors:  E J Weinman; T F Knight; R McKenzie; G Eknoyan
Journal:  Kidney Int       Date:  1976-10       Impact factor: 10.612

View more
  3 in total

Review 1.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 2.  Diuretics. Clinical pharmacology and therapeutic use (Part II).

Authors:  A Lant
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

Review 3.  Diuretic drugs. Progress in clinical pharmacology.

Authors:  A Lant
Journal:  Drugs       Date:  1986       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.